18-FDG PET Imagery and MRI Comparison in Cervical Cancer Lymph Node Metastasis Detection
Data Collection
Urogenital Diseases+10
+ Genital Diseases
+ Uterine Cervical Diseases
Diagnostic Study
Summary
Study start date: October 1, 2003
Actual date on which the first participant was enrolled.Cervical cancer treatment depends on factors like tumor size and lymph node involvement. Early-stage cervical cancers without lymph node involvement are typically treated with surgery, radiotherapy, or both. However, advanced stages often require radio-chemotherapy, either alone or before surgery. Current pre-treatment examinations include a clinical examination and a pelvic MRI to assess lymph nodes and tumor spread. This study aims to explore the potential benefits of using an 18-FDG PET scan alongside the MRI for better lymph node detection in cervical cancer patients, potentially improving treatment planning and outcomes. The study is a multicenter, multidisciplinary effort involving 380 patients over 3 years. Participants will undergo both an 18-FDG PET scan and an MRI before starting any treatment. The results of these scans will be compared to determine which method is more accurate in detecting pelvic and para-aortic lymph node metastasis. The findings will also be correlated with histology results from lymph node dissection. This comparison will help estimate the effectiveness of the 18-FDG PET scan in diagnosing cervical cancer spread.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.42 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Diagnostic Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 3 locations
Médecine Nucléaire
Limoges, FranceOncologie Médicale
Limoges, France